Home/ Stocks/ BSEM

BioStem Technologies, Inc. Common Stock

BSEM XNAS

$1.13 +0.08 (+7.69%) ▲ 15-min delayed

Open

$1.03

High

$1.15

Low

$1.01

Volume

100.8K

Market Cap

$21.10M

About BioStem Technologies, Inc. Common Stock

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 2 Website →

Related Market News

No specific coverage for BSEM yet. Check out our latest market news or earnings calendar.

Get BSEM Alerts

Stay ahead with breaking news, price alerts, and expert analysis on BioStem Technologies, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.